May 9, 2018 / 8:17 PM / in 2 months

BRIEF-Protagonist Therapeutics Reports Q1 Net Loss Per Share $0.36

May 9 (Reuters) - Protagonist Therapeutics Inc:

* PROTAGONIST THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* PROTAGONIST THERAPEUTICS INC - QTRLY NET LOSS PER SHARE $0.36

* PROTAGONIST THERAPEUTICS INC - QTRLY LICENSE AND COLLABORATION REVENUE - RELATED PARTY $10.8 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below